#1 Clinical Trials Search in Europe

Esomeprazole

This article examines the use of esomeprazole (Nexium) in various clinical trials. Esomeprazole is a proton pump inhibitor used to treat conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD) and erosive esophagitis. The trials discussed here investigate its efficacy, safety, and different dosing regimens in various patient populations, including adults and children.

Table of Contents

What is Esomeprazole?

Esomeprazole is a medication commonly used to treat various conditions related to stomach acid. It belongs to a class of drugs called proton pump inhibitors (PPIs). Esomeprazole is also known by its brand name Nexium[1]. This medication works by reducing the amount of acid produced in your stomach, which can help alleviate symptoms and promote healing in certain digestive disorders.

Conditions Treated by Esomeprazole

Esomeprazole is used to treat several conditions related to excessive stomach acid production, including:

  • Gastroesophageal Reflux Disease (GERD): A condition where stomach acid frequently flows back into the esophagus, causing heartburn and other symptoms[1]
  • Erosive Esophagitis: A severe form of GERD where stomach acid causes damage to the lining of the esophagus[2]
  • Non-Erosive Reflux Disease (NERD): A type of GERD where patients experience symptoms without visible damage to the esophagus[3]
  • Chronic Gastritis: Inflammation of the stomach lining[3]
  • Peptic Ulcer Bleeding: A complication of stomach or duodenal ulcers where the ulcer causes bleeding[4]

How Esomeprazole Works

Esomeprazole works by blocking an enzyme in the stomach called the proton pump. This enzyme is responsible for producing stomach acid. By inhibiting this enzyme, esomeprazole reduces the amount of acid in the stomach, which helps alleviate symptoms and allows damaged tissues to heal[1].

Forms and Dosages

Esomeprazole comes in several forms and dosages, including:

  • Oral tablets: Usually available in 20mg and 40mg strengths[5]
  • Gastro-resistant granules for oral suspension: Used especially for children and those who have difficulty swallowing tablets[2]
  • Intravenous (IV) injection: Used in hospital settings for certain conditions[6]

The dosage and duration of treatment depend on the specific condition being treated and can vary from patient to patient. Always follow your doctor’s instructions regarding dosage and duration of treatment.

Effectiveness of Esomeprazole

Research has shown that esomeprazole is effective in treating various acid-related conditions:

  • In patients with GERD, esomeprazole has been shown to reduce nighttime symptoms and improve sleep quality[7]
  • For children with erosive esophagitis, esomeprazole has been effective in maintaining healing over extended periods[2]
  • In patients with peptic ulcer bleeding, high-dose intravenous esomeprazole has been shown to reduce the risk of recurrent bleeding[4]

Potential Side Effects

Like all medications, esomeprazole can cause side effects, although not everyone experiences them. Common side effects may include:

  • Headache
  • Nausea
  • Diarrhea
  • Abdominal pain
  • Constipation
  • Dry mouth

More serious side effects are rare but can occur. These may include an increased risk of bone fractures with long-term use, vitamin B12 deficiency, and an increased risk of certain infections. Always discuss any concerns about side effects with your healthcare provider[3].

Use in Special Populations

Esomeprazole has been studied in various populations:

  • Children: Esomeprazole is approved for use in children as young as 1 year old for certain conditions. The dosage is usually adjusted based on the child’s weight[2]
  • Elderly: No dose adjustment is generally needed for older adults, but they should be monitored closely for potential side effects
  • Pregnant women: The safety of esomeprazole during pregnancy has not been fully established. Always consult with your doctor if you are pregnant or planning to become pregnant

Ongoing Research

Research on esomeprazole is ongoing to further understand its effects and potential uses:

  • Studies are being conducted to compare different dosing regimens and their effectiveness in maintaining symptom control in patients with GERD and chronic gastritis[3]
  • Research is also looking at the effectiveness of esomeprazole in critically ill patients to control stomach acid and prevent complications[6]
  • Investigations are underway to understand how esomeprazole interacts with other medications and how it’s processed by the body[8]

As with any medication, it’s important to take esomeprazole exactly as prescribed by your doctor and to discuss any questions or concerns you may have about your treatment.

Aspect Details
Conditions Studied GERD, Erosive Esophagitis, NERD, Chronic Gastritis, Peptic Ulcer Bleeding
Patient Populations Adults, Children (1-11 years old), Critically ill patients
Administration Methods Oral tablets, Oral suspension, Intravenous injection/infusion
Dosage Ranges 20 mg to 160 mg daily
Primary Outcomes Acid suppression, Healing of esophagitis, Symptom control, Bleeding recurrence
Safety Assessments Adverse events, Clinical laboratory tests, Vital signs, Physical examinations
Study Designs Randomized controlled trials, Crossover studies, Open-label studies
Comparisons Different doses, Oral vs. intravenous administration, Generic vs. brand-name formulations

FAQ

  • What conditions is esomeprazole used to treat in these clinical trials? Esomeprazole is used to treat various conditions in these trials, including gastroesophageal reflux disease (GERD), erosive esophagitis, non-erosive reflux disease (NERD), chronic gastritis, and peptic ulcer bleeding.
  • How is esomeprazole administered in these studies? Esomeprazole is administered in different forms and dosages across the studies. It is given orally as tablets or granules for oral suspension, and intravenously as an injection or infusion. Dosages range from 20 mg to 160 mg per day, depending on the study and condition being treated.
  • What are some of the primary outcomes measured in these trials? Primary outcomes measured include gastric acid suppression, healing of erosive esophagitis, maintenance of healing, symptom control, recurrence of bleeding in peptic ulcer patients, and comparisons of bioequivalence between different formulations of esomeprazole.
  • Are there any studies focusing on pediatric patients? Yes, one study focuses on pediatric patients aged 1 to 11 years old with erosive esophagitis. It aims to assess the efficacy and safety of esomeprazole in maintaining healing of erosive esophagitis in this age group.
  • How do these trials contribute to our understanding of esomeprazole's effectiveness? These trials provide valuable information on esomeprazole's effectiveness in various conditions, its optimal dosing regimens, its performance compared to other formulations, and its safety profile in different patient populations, including adults and children.

Ongoing Clinical Trials on Esomeprazole

  • Study of esomeprazole effects on endoscopic sleeve gastroplasty structural integrity in obese patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Greece

  • Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Iceland

  • Study on the Effectiveness and Safety of SYNB1934 for Adults with Phenylketonuria (PKU)

    Not recruiting

    3 1 1
    Investigated drugs:
    Denmark

Glossary

  • Esomeprazole: A proton pump inhibitor medication used to reduce stomach acid production. It's commonly known by the brand name Nexium.
  • Gastroesophageal Reflux Disease (GERD): A digestive disorder that occurs when stomach acid frequently flows back into the esophagus, causing symptoms like heartburn and regurgitation.
  • Erosive Esophagitis: A condition where the lining of the esophagus becomes inflamed and damaged due to stomach acid, often as a result of GERD.
  • Non-Erosive Reflux Disease (NERD): A type of GERD where patients experience symptoms but do not have visible damage to the esophagus when examined by endoscopy.
  • Proton Pump Inhibitor (PPI): A class of drugs that reduce stomach acid production by blocking the enzyme in the wall of the stomach that produces acid.
  • Bioequivalence: The property of two drug products having the same rate and extent of absorption when administered at the same dose under similar conditions.
  • Endoscopy: A procedure where a long, thin tube with a camera is inserted into the body to examine internal organs, often used to diagnose conditions in the digestive system.
  • Peptic Ulcer: An open sore that develops on the inside lining of the stomach, upper small intestine, or esophagus.
  • Gastritis: Inflammation of the lining of the stomach, which can be acute or chronic.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.

References

  1. https://clinicaltrials.gov/study/NCT00625495
  2. https://clinicaltrials.eu/trial/study-on-esomeprazole-magnesium-for-maintaining-healing-of-erosive-esophagitis-in-children-aged-1-to-11-years/
  3. https://clinicaltrials.gov/study/NCT01119768
  4. https://clinicaltrials.gov/study/NCT01275937
  5. https://clinicaltrials.gov/study/NCT06233149
  6. https://clinicaltrials.gov/study/NCT00428701
  7. https://clinicaltrials.gov/study/NCT01089959
  8. https://clinicaltrials.gov/study/NCT06275841